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diphenyltetrazolium bromide (MTT) assays.
General Procedure for the Preparation of Hydroxylated 2-Amino-3-aryl-4H-chromen-4-ones (1-4).
To a solution of the corresponding methoxylated 2-amino-3-aryl-4H-chromen-4-one precursor (1a-4a, 1 mmol) 1b in acetic acid (2.5 mL) and acetic anhydride (2.5 mL), 57% v/v hydroiodic acid (5 mL) was added dropwise (Scheme 1).
The mixture was refluxed for 6 h. After solvent evaporation in vacuo, water (10 mL) was added to the residue; the solid obtained was filtered and washed with water (2 x 5 mL) (76-86% yield). Each compound was purified by preparative reverse-phase HPLC as described above. -7-hydroxy-3-phenyl-4H-chromen-4-one (1 6.67 (m, 1H, Ar), 6.81 (s, 1H, Ar), 6.90 (m, 1H, Ar) , 7.04 (s, 2H, NH 2 ), 7.48 (m, 2H, Ar), 7.73 (m, 1H, Ar), 7.94 (d, J = 8.5 Hz, 2H, Ar), 8.88 (s, 1H, OH), 8.94 (s, 1H, OH) . 13 C NMR (125 MHz, DMSO-d 6 )/δ (ppm): 173.1, 162. 8, 153.0, 145.6, 114.8, 132.4, 125.7, 124.8, 124.4, 123.5, 122.4, 119.1, 116.8, 116.3, 99.7 -3-(3,4-dihydroxyphenyl)-6-chloro-4H-chromen-4-one (3 6 )/δ (ppm): 168. 9, 164.7, 151.1, 145.9, 145.6, 132.9, 129.7, 124.4, 122.7, 122.4, 122.0, 119.3, 118.8, 116.6, 101.3 -3-(3,4-dihydroxyphenyl)-7-hydroxy-4H-chromen-4-one (4 4, 162.1, 154.2, 145.8, 145.4, 126.9, 122.6, 119.0, 116.5, 114.4, 113.2, 102.0, 99.4 
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2-Amino-3-(3,4-dihydroxyphenyl)-4H-chromen-4-one (2)
.
2-Amino
Determination of Solution Speciation from Acidity Constants for
Aminoisoflavones and Stability Constants for Cu(II)−4 Complexes. The acidity constants (pK a ) for 1-4 were determined by spectrophotometric variable-pH titrations with modifications to the previously described methods. 2, 3, 6, 7 A solution (10 mM NaOH, 100 mM NaCl, pH 12) containing 1 (30 µM) was titrated with small aliquots of HCl to acquire at least 30 spectra in the range from pH 1.5-12. Solutions of 2 (20 µM), 3 (15 µM), and 4 (30 µM) in 200 mM HCl, 100 mM NaCl, pH 0.6 were titrated with small aliquots of NaOH and at least 30 spectra were acquired from pH 0. 6-12.4 . To measure the stability constants (logβ) for the Cu(II)−4 complexes, 4 (30 µM) and CuCl 2 in a ratio of 2:1 were added to a solution (10 mM NaOH, 100 mM NaOH) at pH 8. Following overnight incubation, the solution was titrated with small aliquots of HCl in the range from pH 4-8. The pK a and logβ values were calculated using the program HypSpec (Protonic Software, UK). 8 Speciation diagrams were generated from the calculated values by the program HySS2009 (Protonic Software, UK). was also studied by measuring changes in the optical spectra. In the same buffered solution, Aβ (10 µM) was pre-incubated with CuCl 2 (5 or 10 µM) for 5 min, followed by the addition of 0.5, 1, or 2 equiv of 4 (20 µM) was pre-incubated with CuCl 2 for 5 min, Representative conformations were selected for docking from those within the PDB file (1, 3, 8, 10, 12, 13, 16, 17, 20 for 2LFM, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 for 2LMN and 2LMO) . The MMFF94 energy minimization function in ChemBio3D Ultra 11.0 was used to optimize the structure of aminoisoflavones for the docking studies. Individual structures of Aβ and aminoisoflavones were prepared using AutoDock Tools. 12 The search space was constrained to the dimensions of the peptide. The exhaustiveness for the docking runs was set at 1024. Docked models of the aminoisoflavones were visualized with Aβ 40 using Pymol.
NMR Sample Preparation.
Prior to the preparation of the Aβ 40 sample for NMR, the peptide was dissolved in ammonium hydroxide (NH 4 OH, 2% v/v aq) at 1 mg/ml to remove any preformed aggregates. 13 Volumes equivalent to 0.1 mg (100 µL) were then aliquoted and lyophilized. The lyophilized peptide was initially dissolved in 1 mM NaOH and then allowed to solubilize at 4 °C until the solution became clear (ca. 1 h were assigned based on previous assignments under similar conditions. 16 For the STD experiments, both 1 and 4 were kept at a molar ratio of 10:1 relative to the fibril (200 µM to 20 µM). 13 For the STD experiment, a 3 s train of Gaussian-shaped 50 ms pulses was employed to selectively saturate the amyloid fibril. 17 The saturation pulses were centered on −2 and 100 ppm for on and off resonance respectively. The magnitude of the STD effect for each peak was calculated by dividing the normalized signal intensity in the on resonance spectrum by its corresponding intensity in the off resonance reference spectrum.
Trolox Equivalence Antioxidant Capacity (TEAC) Assay. The TEAC assay was used to determine the antioxidant ability based on the extent of decolorization of ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt) cation radical relative to that of the vitamin E analogue, Trolox. 18a The assay was performed according to the previously reported method with slight modifications. calculated as a ratio of the slope of the standard curve of the compound to that of Trolox. The measurements were carried out in triplicate. Table S1 . Thermodynamic values for the interaction of 1, 2, and 4 with Aβ 40 determined by isothermal titration calorimetry (ITC). Table S1 . Thermodynamic values for the interaction of 1, 2, and 4 with Aβ 40 determined by isothermal titration calorimetry (ITC). (1a, 2a, and 4a) . Top: Structures of 1a (2-amino-7-methoxy-3-phenyl-4H-chromen-4-one), 2a (2-amino-3-(3,4-dimethoxyphenyl)-4H-chromen-4-one), and 4a (2-amino-3-(3,4-dimethoxyphenyl)-7-methoxy-4H-chromen-4-one 
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